The purpose of this paper is to promote understanding of cognitive impairment in multiple sclerosis (MS), recommend optimal screening, monitoring, and treatment strategies, and address barriers to optimal management. To accomplish this the National MS Society convened experts in cognitive dysfunction (clinicians, researchers, and lay people with MS) to review the published literature, reach consensus on optimal strategies for screening, monitoring, and treating cognitive changes, and propose strategies to address barriers to optimal care. Based on current evidence, the Society has made recommendations, endorsed by the Consortium of Multiple Sclerosis Centers and the International Multiple Sclerosis Cognition Society. Read the paper now.
- Thursday September 24th @ 6:30 Roanoke Valley MS Support Group Meeting
- Kroger and Amazon Smiles: A Great way to Support Us
- Help Us Make A MS Alliance of Virginia Cookbook
- Government study evaluating Rebif® (interferon beta-1a) as COVID-19 treatment
- Cashew shell compound appears to mend damaged nerves
- New MS Drug Approved “Kesimpta” by Novartis
- Cruise with Royal Caribbean Enchantment of the Sea
- What Is COVID-19 Doing to the Brain?
- Reiki: What Can This Energy Therapy Do for Multiple Sclerosis?
- New oral treatment, Zeposia, available for relapsing forms of MS